325 related articles for article (PubMed ID: 9582275)
21. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo.
Diehl NL; Enslen H; Fortner KA; Merritt C; Stetson N; Charland C; Flavell RA; Davis RJ; Rincón M
J Exp Med; 2000 Jan; 191(2):321-34. PubMed ID: 10637276
[TBL] [Abstract][Full Text] [Related]
22. Selective requirement of p38alpha MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses.
Berenson LS; Yang J; Sleckman BP; Murphy TL; Murphy KM
J Immunol; 2006 Apr; 176(8):4616-21. PubMed ID: 16585552
[TBL] [Abstract][Full Text] [Related]
23. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells.
DeSilva DR; Jones EA; Feeser WS; Manos EJ; Scherle PA
Cell Immunol; 1997 Sep; 180(2):116-23. PubMed ID: 9341741
[TBL] [Abstract][Full Text] [Related]
24. Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase.
Hashimoto S; Matsumoto K; Gon Y; Nakayama T; Takeshita I; Horie T
Am J Respir Crit Care Med; 1999 Feb; 159(2):634-40. PubMed ID: 9927384
[TBL] [Abstract][Full Text] [Related]
25. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.
Lim CP; Jain N; Cao X
Oncogene; 1998 Jun; 16(22):2915-26. PubMed ID: 9671412
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha.
Hashimoto S; Matsumoto K; Gon Y; Furuichi S; Maruoka S; Takeshita I; Hirota K; Yodoi J; Horie T
Biochem Biophys Res Commun; 1999 May; 258(2):443-7. PubMed ID: 10329406
[TBL] [Abstract][Full Text] [Related]
27. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.
Goedert M; Cuenda A; Craxton M; Jakes R; Cohen P
EMBO J; 1997 Jun; 16(12):3563-71. PubMed ID: 9218798
[TBL] [Abstract][Full Text] [Related]
28. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
Kumar S; McDonnell PC; Gum RJ; Hand AT; Lee JC; Young PR
Biochem Biophys Res Commun; 1997 Jun; 235(3):533-8. PubMed ID: 9207191
[TBL] [Abstract][Full Text] [Related]
29. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice.
Kanakaraj P; Ngo K; Wu Y; Angulo A; Ghazal P; Harris CA; Siekierka JJ; Peterson PA; Fung-Leung WP
J Exp Med; 1999 Apr; 189(7):1129-38. PubMed ID: 10190904
[TBL] [Abstract][Full Text] [Related]
30. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes.
Heo Y; Lee WT; Lawrence DA
Toxicol Sci; 1998 Jun; 43(2):172-85. PubMed ID: 9710959
[TBL] [Abstract][Full Text] [Related]
32. Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-gamma production.
Badou A; Savignac M; Moreau M; Leclerc C; Foucras G; Cassar G; Paulet P; Lagrange D; Druet P; Guéry JC; Pelletier L
Eur J Immunol; 2001 Aug; 31(8):2487-96. PubMed ID: 11500833
[TBL] [Abstract][Full Text] [Related]
33. Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation.
Li B; Yu H; Zheng W; Voll R; Na S; Roberts AW; Williams DA; Davis RJ; Ghosh S; Flavell RA
Science; 2000 Jun; 288(5474):2219-22. PubMed ID: 10864872
[TBL] [Abstract][Full Text] [Related]
34. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells.
Merritt C; Enslen H; Diehl N; Conze D; Davis RJ; Rincón M
Mol Cell Biol; 2000 Feb; 20(3):936-46. PubMed ID: 10629051
[TBL] [Abstract][Full Text] [Related]
35. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes.
Sugawara T; Moriguchi T; Nishida E; Takahama Y
Immunity; 1998 Oct; 9(4):565-74. PubMed ID: 9806642
[TBL] [Abstract][Full Text] [Related]
36. TLR2 Involved in Naive CD4+ T Cells Rescues Stress-Induced Immune Suppression by Regulating Th1/Th2 and Th17.
Zhao J; Liu J; Denney J; Li C; Li F; Chang F; Chen M; Yin D
Neuroimmunomodulation; 2015; 22(5):328-36. PubMed ID: 25721027
[TBL] [Abstract][Full Text] [Related]
37. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
Eyers PA; Craxton M; Morrice N; Cohen P; Goedert M
Chem Biol; 1998 Jun; 5(6):321-8. PubMed ID: 9653550
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.
Yang DD; Conze D; Whitmarsh AJ; Barrett T; Davis RJ; Rincón M; Flavell RA
Immunity; 1998 Oct; 9(4):575-85. PubMed ID: 9806643
[TBL] [Abstract][Full Text] [Related]
39. Defective T cell differentiation in the absence of Jnk1.
Dong C; Yang DD; Wysk M; Whitmarsh AJ; Davis RJ; Flavell RA
Science; 1998 Dec; 282(5396):2092-5. PubMed ID: 9851932
[TBL] [Abstract][Full Text] [Related]
40. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
